Table 1.
Participants characteristics.
| Characteristic | Values |
|---|---|
| Sex (M/F) | 22/7 |
| Age (years) | 51±11.2 |
| Type 2 diabetes diagnosis (years) | 5.7±6.0 (0.1–20) |
| Height (cm) | 167.8±7.4 |
| Weight (kg) | 69.9±10.6 |
| BMI (kg/m2) | 24.8±3.4 |
| Diastolic blood pressure (mmHg) | 78±8 |
| Systolic blood pressure (mmHg) | 125±13 |
| HbA1C (%) | 7.3±1.3 |
| HbA1c (mmol/mol) | 56.2±14.5 |
| Fasting glucose (mmol/L) | 7.2±1.3 |
| Blood uric acid (μmol/L) | 347.0±73.5 |
| Creatinine (μmol/L) | 72.2±15.2 |
| Cholesterol (mmol/L) | 4.5±0.9 |
| Triacylglycerol (mmol/L) | 1.9±1.5 |
| HDL-C (mmol/L) | 1.2±0.2 |
| LDL-C (mmol/L) | 2.2±0.6 |
| Glucose-lowering medication (n) | 14 |
| Metformin + Sulfonylurea | 4 |
| Metformin + Repaglinide | 1 |
| Metformin + Acarbose | 1 |
| Metformin + DPP4 inhibitor | 3 |
| Sulfonylurea + Thiazolidinedione | 1 |
| Sulfonylurea + Acarbose | 3 |
| Acarbose + Repaglinide | 1 |